17-82519935-CGGGCGGCGGGGCCGG-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM4BP6_ModerateBA1
The NM_004514.4(FOXK2):βc.73_87delβ(p.Ala25_Gly29del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0868 in 982,526 control chromosomes in the GnomAD database, including 3,766 homozygotes. Variant has been reported in ClinVar as Likely benign (β ).
Frequency
Genomes: π 0.080 ( 518 hom., cov: 27)
Exomes π: 0.088 ( 3248 hom. )
Consequence
FOXK2
NM_004514.4 inframe_deletion
NM_004514.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.10
Genes affected
FOXK2 (HGNC:6036): (forkhead box K2) The protein encoded by this gene contains a fork head DNA binding domain. This protein can bind to the purine-rich motifs of the HIV long terminal repeat (LTR), and to the similar purine-rich motif in the interleukin 2 (IL2) promoter. It may be involved in the regulation of viral and cellular promoter elements. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_004514.4.
BP6
Variant 17-82519935-CGGGCGGCGGGGCCGG-C is Benign according to our data. Variant chr17-82519935-CGGGCGGCGGGGCCGG-C is described in ClinVar as [Likely_benign]. Clinvar id is 770801.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FOXK2 | NM_004514.4 | c.73_87del | p.Ala25_Gly29del | inframe_deletion | 1/9 | ENST00000335255.10 | |
FOXK2 | XM_047435919.1 | c.73_87del | p.Ala25_Gly29del | inframe_deletion | 1/9 | ||
FOXK2 | XM_047435920.1 | c.73_87del | p.Ala25_Gly29del | inframe_deletion | 1/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FOXK2 | ENST00000335255.10 | c.73_87del | p.Ala25_Gly29del | inframe_deletion | 1/9 | 1 | NM_004514.4 | P1 | |
FOXK2 | ENST00000473637.6 | c.73_87del | p.Ala25_Gly29del | inframe_deletion, NMD_transcript_variant | 1/10 | 1 | |||
FOXK2 | ENST00000527313.6 | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0801 AC: 11581AN: 144618Hom.: 518 Cov.: 27
GnomAD3 genomes
AF:
AC:
11581
AN:
144618
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0278 AC: 3AN: 108Hom.: 0 AF XY: 0.0333 AC XY: 2AN XY: 60
GnomAD3 exomes
AF:
AC:
3
AN:
108
Hom.:
AF XY:
AC XY:
2
AN XY:
60
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
GnomAD4 exome AF: 0.0880 AC: 73728AN: 837888Hom.: 3248 AF XY: 0.0886 AC XY: 34320AN XY: 387426
GnomAD4 exome
AF:
AC:
73728
AN:
837888
Hom.:
AF XY:
AC XY:
34320
AN XY:
387426
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0801 AC: 11588AN: 144638Hom.: 518 Cov.: 27 AF XY: 0.0783 AC XY: 5506AN XY: 70316
GnomAD4 genome
AF:
AC:
11588
AN:
144638
Hom.:
Cov.:
27
AF XY:
AC XY:
5506
AN XY:
70316
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at